418 related articles for article (PubMed ID: 22108446)
1. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
Ford AC; Khan KJ; Achkar JP; Moayyedi P
Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
Ford AC; Khan KJ; Sandborn WJ; Hanauer SB; Moayyedi P
Clin Gastroenterol Hepatol; 2012 May; 10(5):513-9. PubMed ID: 22083024
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis.
Barberio B; Segal JP; Quraishi MN; Black CJ; Savarino EV; Ford AC
J Crohns Colitis; 2021 Jul; 15(7):1184-1196. PubMed ID: 33433562
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.
Nguyen NH; Fumery M; Dulai PS; Prokop LJ; Sandborn WJ; Murad MH; Singh S
Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):742-753. PubMed ID: 30122356
[TBL] [Abstract][Full Text] [Related]
7. Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.
Ford AC; Khan KJ; Sandborn WJ; Kane SV; Moayyedi P
Am J Gastroenterol; 2011 Dec; 106(12):2070-7; quiz 2078. PubMed ID: 21894226
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis.
Nikfar S; Rahimi R; Rezaie A; Abdollahi M
Dig Dis Sci; 2009 Jun; 54(6):1157-70. PubMed ID: 18770034
[TBL] [Abstract][Full Text] [Related]
10. 5-aminosalicylates prevent relapse of Crohn's disease after surgically induced remission: systematic review and meta-analysis.
Ford AC; Khan KJ; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Mar; 106(3):413-20. PubMed ID: 20717106
[TBL] [Abstract][Full Text] [Related]
11. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560
[TBL] [Abstract][Full Text] [Related]
12. Oral or Topical 5-ASA in Ulcerative Colitis.
Hanauer SB
Dig Dis; 2016; 34(1-2):122-4. PubMed ID: 26982709
[TBL] [Abstract][Full Text] [Related]
13. Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis.
Tong JL; Huang ML; Xu XT; Qiao YQ; Ran ZH
J Dig Dis; 2012 Apr; 13(4):200-7. PubMed ID: 22435504
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Bernstein CN; Khan KJ; Abreu MT; Marshall JK; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):590-9; quiz 600. PubMed ID: 21407179
[TBL] [Abstract][Full Text] [Related]
15. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gordon M; Naidoo K; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2011 Jan; (1):CD008414. PubMed ID: 21249709
[TBL] [Abstract][Full Text] [Related]
16. Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.
Feagan BG; MacDonald JK
Inflamm Bowel Dis; 2012 Sep; 18(9):1785-94. PubMed ID: 22644954
[TBL] [Abstract][Full Text] [Related]
17. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Hanauer S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Ford AC; Sandborn WJ; Khan KJ; Hanauer SB; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):644-59, quiz 660. PubMed ID: 21407183
[TBL] [Abstract][Full Text] [Related]
19. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
Richter JM; Kushkuley S; Barrett JA; Oster G
Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.
Kane SV; Bjorkman DJ
Rev Gastroenterol Disord; 2003; 3(4):210-8. PubMed ID: 14668693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]